HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hypertensive putaminal hemorrhage: treatment and results. Is surgical treatment superior to conservative one?

Abstract
Seventy-four patients with hypertensive putaminal hemorrhage (HPH) were followed at least 6 months after treatment and estimated by ADL. They were graded according to the state of consciousness on admission. The grading consists of 6 grades: Grade 1, fully conscious; Grade 2, somnolent; Grade 3, stuporous; Grade 4, semi-comatose; and Grade 5, deeply comatose. Removal of HPH was performed in 18 patients and conservative treatment was done in 56 patients. The mortality in surgically treated group was 28% while that in conservatively treated group was 14%. The patients who returned to full work or independent life without disability and with minimal disability after surgical treatment were, 50% in Grade 1, 33% in Grade 2, and 50% in Grade 3. The patients without disability and with minimal disability after conservative treatment were; 87% in Grade 1, 80% in Grade 2, and 22% in Grade 3. None below Grade 4 returned to full work or independent life in both groups. There was good correlation between the state of consciousness and CT findings on admission. There was no correlation between good recovery and the side of HPH. Our results do not support the view that the surgical treatment is superior to the conservative one in the management of HPH.
AuthorsS Waga, Y Yamamoto
JournalStroke (Stroke) 1983 Jul-Aug Vol. 14 Issue 4 Pg. 480-5 ISSN: 0039-2499 [Print] United States
PMID6658920 (Publication Type: Comparative Study, Journal Article)
Topics
  • Activities of Daily Living
  • Adult
  • Aged
  • Cerebral Hemorrhage (surgery, therapy)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neurologic Examination
  • Putamen

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: